Scott Turner

Company: Pliant Therapeutics
Job title: Senior Vice President of Research
Seminars:
Reprograming the immunosuppressive tumour microenvironment with selective integrin inhibition 2:00 pm
Inhibition of avb8 and avb1 promotes ifng and suppresses tgfb signalling in tumors Reprograming tumor cytokine levels promotes proinflammatory cell infiltration and suppress stromal protein synthesis Treatment was synergistic with checkpoint inhibitors in multiple murine tumor modelsRead more
day: Day One